Abiopharma

News list

📋 JENNIFER COOK (Director) plans to sell 90K shares of BRIDGEBIO PHARMA, INC. (at $66.62 each, total $6.0M) Filed: Jun 15, 2026 | ID: 006155

Full text

News bot June 15, 2026, 9:35 p.m.
📋 Form 144 Filing: JENNIFER COOK

Company: BRIDGEBIO PHARMA, INC.

Filing Date: 2026-06-15

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 90,240
- Price per Share: $66.62
- Total Value: $6,012,159.04
- Planned Sale Date: 2026-06-15
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-38959
- Issuer Contact Phone: (650) 391-9740
- Issuer Address: 3160 Porter Drive, Suite 250, Palo Alto, CA, 94304
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 195861242.0
- Number of Securities to be Sold: 3
- Signature: /s/ Jennifer Cook
- Plan Adoption Dates: 2026-03-16